Search

Carl J. Arbes

Examiner (ID: 12863, Phone: (571)272-4563 , Office: P/3729 )

Most Active Art Unit
3729
Art Unit(s)
3726, 2103, 3727, 3206, 3201, 3202, 3729, 2899, 2831
Total Applications
4677
Issued Applications
4193
Pending Applications
65
Abandoned Applications
435

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19018866 [patent_doc_number] => 20240075037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => SKIN BARRIER FUNCTION IMPROVING AGENT [patent_app_type] => utility [patent_app_number] => 18/162859 [patent_app_country] => US [patent_app_date] => 2023-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6273 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18162859 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/162859
SKIN BARRIER FUNCTION IMPROVING AGENT Jan 31, 2023 Pending
Array ( [id] => 18497354 [patent_doc_number] => 20230219976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR [patent_app_type] => utility [patent_app_number] => 18/104045 [patent_app_country] => US [patent_app_date] => 2023-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104045 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/104045
AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR Jan 30, 2023 Abandoned
Array ( [id] => 18844881 [patent_doc_number] => 20230407285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => PCSK9 INHIBITORS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/159270 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64130 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159270 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159270
PCSK9 INHIBITORS AND METHODS OF USE THEREOF Jan 24, 2023 Pending
Array ( [id] => 18574200 [patent_doc_number] => 11730706 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-08-22 [patent_title] => Treatment of depression in certain patient populations [patent_app_type] => utility [patent_app_number] => 18/158268 [patent_app_country] => US [patent_app_date] => 2023-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4573 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18158268 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/158268
Treatment of depression in certain patient populations Jan 22, 2023 Issued
Array ( [id] => 18647916 [patent_doc_number] => 20230293695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => Tamper Resistant Pharmaceutical Formulations [patent_app_type] => utility [patent_app_number] => 18/095691 [patent_app_country] => US [patent_app_date] => 2023-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9454 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18095691 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/095691
Tamper Resistant Pharmaceutical Formulations Jan 10, 2023 Abandoned
Array ( [id] => 18363616 [patent_doc_number] => 20230145207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/150933 [patent_app_country] => US [patent_app_date] => 2023-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9981 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150933 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/150933
PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES AND METHODS OF USE Jan 5, 2023 Pending
Array ( [id] => 18389758 [patent_doc_number] => 20230157976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => HEXYLAMINE SALTS AND METHODS OF USING HEXYLAMINE [patent_app_type] => utility [patent_app_number] => 18/092818 [patent_app_country] => US [patent_app_date] => 2023-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6025 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18092818 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/092818
Hexylamine salts and methods of using hexylamine Jan 2, 2023 Issued
Array ( [id] => 18374248 [patent_doc_number] => 20230149325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => HEXYLAMINE SALTS AND METHODS OF USING HEXYLAMINE [patent_app_type] => utility [patent_app_number] => 18/092800 [patent_app_country] => US [patent_app_date] => 2023-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18092800 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/092800
Hexylamine salts and methods of using hexylamine Jan 2, 2023 Issued
Array ( [id] => 20437423 [patent_doc_number] => 12508244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-30 [patent_title] => Therapeutic agent for non-motor symptoms associated with Parkinson's disease [patent_app_type] => utility [patent_app_number] => 18/089752 [patent_app_country] => US [patent_app_date] => 2022-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 13638 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 567 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18089752 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/089752
Therapeutic agent for non-motor symptoms associated with Parkinson's disease Dec 27, 2022 Issued
Array ( [id] => 18610829 [patent_doc_number] => 20230277559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => Compositions and Methods for the Treatment of Inflammation in Urological Pathology [patent_app_type] => utility [patent_app_number] => 18/146665 [patent_app_country] => US [patent_app_date] => 2022-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27616 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146665 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/146665
Compositions and Methods for the Treatment of Inflammation in Urological Pathology Dec 26, 2022 Pending
Array ( [id] => 19372861 [patent_doc_number] => 12064400 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-08-20 [patent_title] => Method and system for reducing active ingredient potency in pain-management compositions to a quarter amount of approved levels [patent_app_type] => utility [patent_app_number] => 18/087680 [patent_app_country] => US [patent_app_date] => 2022-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 13102 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18087680 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/087680
Method and system for reducing active ingredient potency in pain-management compositions to a quarter amount of approved levels Dec 21, 2022 Issued
Array ( [id] => 18339108 [patent_doc_number] => 20230131057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM [patent_app_type] => utility [patent_app_number] => 18/065013 [patent_app_country] => US [patent_app_date] => 2022-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065013 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/065013
PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM Dec 12, 2022 Pending
Array ( [id] => 18375842 [patent_doc_number] => 20230150923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => NOVEL AROMATIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/064576 [patent_app_country] => US [patent_app_date] => 2022-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18064576 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/064576
NOVEL AROMATIC COMPOUNDS Dec 11, 2022 Pending
Array ( [id] => 18375842 [patent_doc_number] => 20230150923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => NOVEL AROMATIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/064576 [patent_app_country] => US [patent_app_date] => 2022-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18064576 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/064576
NOVEL AROMATIC COMPOUNDS Dec 11, 2022 Pending
Array ( [id] => 18296534 [patent_doc_number] => 20230106220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => METHOD FOR TREATMENT OF ROSACEA [patent_app_type] => utility [patent_app_number] => 18/076444 [patent_app_country] => US [patent_app_date] => 2022-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13046 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076444 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/076444
Method for treatment of rosacea Dec 6, 2022 Issued
Array ( [id] => 18792637 [patent_doc_number] => 11826370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-28 [patent_title] => Pharmaceutical compositions comprising meloxicam [patent_app_type] => utility [patent_app_number] => 18/062729 [patent_app_country] => US [patent_app_date] => 2022-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 35 [patent_no_of_words] => 24891 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062729 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/062729
Pharmaceutical compositions comprising meloxicam Dec 6, 2022 Issued
Array ( [id] => 18466855 [patent_doc_number] => 20230201135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => USE OF ATOVAQUONE AND PROGUANIL FOR TREATMENT OF GASTROINTESTINAL DISEASES AND INFLAMMATION [patent_app_type] => utility [patent_app_number] => 18/073885 [patent_app_country] => US [patent_app_date] => 2022-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18080 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18073885 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/073885
Use of atovaquone and proguanil for treatment of gastrointestinal diseases and inflammation Dec 1, 2022 Issued
Array ( [id] => 18930991 [patent_doc_number] => 11883385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome [patent_app_type] => utility [patent_app_number] => 18/061206 [patent_app_country] => US [patent_app_date] => 2022-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10406 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061206 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/061206
Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome Dec 1, 2022 Issued
Array ( [id] => 18737816 [patent_doc_number] => 20230346713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/061081 [patent_app_country] => US [patent_app_date] => 2022-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061081 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/061081
METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS Dec 1, 2022 Issued
Array ( [id] => 18389799 [patent_doc_number] => 20230158017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => METHODS FOR TREATING DEPRESSIVE SYMPTOMS [patent_app_type] => utility [patent_app_number] => 18/056975 [patent_app_country] => US [patent_app_date] => 2022-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056975 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/056975
Methods for treating depressive symptoms Nov 17, 2022 Issued
Menu